Sulfobutyl Ether Beta Cyclodextrin Sodium for Injection | SBECD Pharmaceutical Excipient
CAS No.: 182410-00-0
Other Name: Sulfobutyl Ether Beta Cyclodextrin Sodium; SBECD; SBE-β-CD
Appearance: White to off-white amorphous powder
Molecular Formula: C42H70-nO35(C4H8SO3Na)n
Average Degree of Substitution: 6.2–6.9
Shelf Life: 36 Months
Grade: Injectable Pharmaceutical Grade
Standards: USP / EP / BP / ChP
Application: Pharmaceutical Excipients
Assay: 95.0%–105.0%
Bacterial Endotoxins: <0.005 EU/mg
pH: 4.0–6.8
Package Specification: 0.5 kg/bag, 1 kg/bag, 10 kg/bag, 10 kg/drum, 20 kg/drum
Sulfobutyl Ether Beta Cyclodextrin Sodium (SBECD), also known as Betadex Sulfobutyl Ether Sodium or SBE-β-CD, is a highly water-soluble anionic derivative of beta-cyclodextrin. It is widely used as a pharmaceutical excipient, particularly in injectable drug formulations.
With its hydrophilic sulfobutyl ether groups and hydrophobic inner cavity, SBECD can form reversible inclusion complexes with suitable active pharmaceutical ingredients (APIs). This helps improve the apparent aqueous solubility of poorly water-soluble drugs and supports pharmaceutical formulation development.
SBECD is primarily used as a solubilizing excipient in injectable pharmaceutical formulations, including intravenous products. It helps improve the aqueous solubility of suitable poorly soluble APIs.
SBECD is used in certain antifungal formulations to enhance drug solubility and support the development of aqueous dosage forms.
Its inclusion complex-forming properties make SBECD useful in selected antiviral formulations where improved drug solubility is required.
SBECD can serve as a solubilizing excipient during the formulation development of selected poorly water-soluble oncology compounds.
SBECD is used in formulation research to investigate drug-cyclodextrin inclusion complexes, solubility enhancement and formulation stability.
| Product Name | Betadex Sulfobutyl Ether Sodium |
| Other Names | Sulfobutyl Ether Beta Cyclodextrin Sodium, SBECD, SBE-β-CD |
| CAS No. | 182410-00-0 |
| Molecular Formula | C42H70-nO35(C4H8SO3Na)n |
| Molecular Weight | 1134 + 158n |
| Appearance | White to off-white amorphous powder |
| Grade | Injectable Pharmaceutical Excipient |
| Standards | USP / EP |
| Assay | 95.0%–105.0% |
| Average Degree of Substitution | 6.2–6.9 |
| Solubility | Freely soluble in water |
| Bacterial Endotoxins | ≤10 EU/g |
| Shelf Life | 36 months |
The above information provides a general product overview. Please refer to the latest product specification and batch-specific Certificate of Analysis (COA) for official acceptance criteria.
Quality consistency is essential for pharmaceutical excipients used in parenteral formulations. Our SBECD is subject to quality control procedures throughout the production process, with particular attention to the following quality attributes:
Batch-specific quality documentation, including a Certificate of Analysis (COA), is available to support customer quality evaluation and documentation requirements.
SBECD is available in different packaging options to meet laboratory evaluation, formulation development and commercial production requirements.
Xi'an DELI Biochemical Industry Co., Ltd. was established in 1999 and has over 26 years of experience in the cyclodextrin industry. We specialize in cyclodextrins and their derivatives, including Hydroxypropyl Betadex (HPBCD) and Betadex Sulfobutyl Ether Sodium (SBECD).
Our company operates an ISO 9001-certified quality management system and maintains quality control procedures throughout the production process to support the requirements of pharmaceutical customers.
Relevant regulatory documentation and product registration information are available for customer evaluation, including US FDA DMF information for applicable products.
With dedicated production facilities and established process controls, Xi'an DELI Biochemical provides SBECD for pharmaceutical development and commercial applications.
Our annual production capacity exceeds 200 metric tons, with a typical batch size of approximately 2.5 metric tons. This production capability supports batch supply and long-term cooperation with pharmaceutical customers worldwide.
Q1: What is SBECD used for in pharmaceutical formulations?
A: SBECD is primarily used as a solubilizing excipient. It forms inclusion complexes with suitable drug molecules to improve the apparent aqueous solubility of poorly water-soluble APIs.
Q2: What is the CAS number of SBECD?
A: The CAS number of Betadex Sulfobutyl Ether Sodium is 182410-00-0.
Q3: What is the average degree of substitution of your SBECD?
A: Our product has an average degree of substitution of 6.2–6.9, according to the applicable product specification.
Q4: Is SBECD suitable for injectable pharmaceutical formulations?
A: SBECD is primarily used as a pharmaceutical excipient in selected injectable formulations. Its suitability for a specific drug product should be evaluated according to formulation requirements and applicable regulatory standards.
Q5: Which pharmacopoeial standards does your SBECD follow?
A: Our SBECD product is tested according to applicable USP and EP requirements. Please contact us for the latest specification and COA.
Q6: Can you provide a DMF and technical documentation?
A: Relevant regulatory and technical documents, including available DMF information, product specifications and COA, can be provided for customer evaluation.
Q7: Can you provide samples for formulation development?
A: Yes. Samples can be discussed for pharmaceutical research, formulation development and product evaluation.
Looking for Betadex Sulfobutyl Ether Sodium (SBECD), CAS 182410-00-0, for injectable pharmaceutical applications?
Contact Xi'an DELI Biochemical Industry Co., Ltd. for product specifications, COA, technical documentation, samples and quotations. We welcome inquiries from pharmaceutical companies, formulation developers and pharmaceutical excipient distributors worldwide.
Company: Xi'an DELI Biochemical Industry Co., Ltd.
Website: https://www.delicydextrin.com/
Email: stella@xadl.com
Sulfobutyl Ether Beta Cyclodextrin Powder Injectable Grade Pharmaceutical Excipient
Betadex Sulfobutyl Ether Sodium CAS NO 182410-00-0
Sulfobutyl Ether Beta Cyclodextrin Sodium
Betadex Sulfobutyl Ether Sodium Injection Grade
Betadex Sulfobutyl Ether Sodium SBECD Injectable Grade for Drug Formulations
Betadex Sulfobutyl Ether Sodium CAS 182410-00-0